Inhibitory effects of NSAID-conjugated SN-38 on the viability of A549 Non-small cell lung cancer cells
The goal of this paper was to look into the anti-tumor mechanism of Non-Steroidal Anti-Inflammatory Drug (NSAID)-conjugated SN-38 Prodrug in A549 lung cancer cells. We found that Indomethacine–SN–38 (IndoSN-38) and Naproxen–SN–38(NaproSN-38) as a theranostic prodrug targeting cyclooxygenase-2(COX-2)...
Main Authors: | Hae–Won Kwon, Jusung An, Jong Seung Kim, In-Cheol Kang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-09-01
|
Series: | Biochemistry and Biophysics Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580823000985 |
Similar Items
-
Generation of anti-SN38 antibody for loading efficacy and therapeutic monitoring of SN38-containing therapeutics
by: Tahereh Zarnoosheh Farahani, et al.
Published: (2024-06-01) -
Research Progress of SN38 Drug Delivery System in Cancer Treatment
by: Qi QR, et al.
Published: (2024-01-01) -
Ultrasound-triggered with ROS-responsive SN38 nanoparticle for enhanced combination cancer immunotherapy
by: Hongyu Liu, et al.
Published: (2024-03-01) -
Liposomal codelivery of an SN38 prodrug and a survivin siRNA for tumor therapy
by: Bi Y, et al.
Published: (2018-10-01) -
Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy
by: Xie J, et al.
Published: (2016-04-01)